From: Reduced risk of post ERCP pancreatitis in statin users
Variable | Odds Ratio | 95% Confidence Interval | p value |
---|---|---|---|
Age | 0.99 | (0.97–0.99) | 0.033 |
Statin use | 0.35 | (0.18–0.69) | 0.002 |
Sphincterotomy | 2.85 | (1.7–4.78) | 0.0001 |
History of post ERCP pancreatitis | 2.41 | (1.051–5.507) | 0.038 |
Statin Use by intensitya | |||
No statin use | Reference | Reference | Reference |
Low intensity statin | 0.43 | 0.208–0.898 | 0.025 |
High intensity statin | 0.20 | 0.047–0.820 | 0.026 |
Statin Use by typea | |||
No statin use | Reference | Reference | Reference |
Lipophilic statin use | 0.4 | 0.193–0.830 | 0.014 |
Hydrophilic statin use | 0.23 | 0.056–0.982 | 0.047 |